Patents by Inventor Jacques Pillot

Jacques Pillot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5619000
    Abstract: The present invention relates to a method of producing a sintered body comprising one or more hard constituents and a binder phase based on cobalt, nickel and/or iron by powder metallurgical methods milling, pressing and sintering of powders. At least part of the binderphase powder consists of non-agglomerated particles of spheroidal morphology having dimensions of 0.1 to 20 .mu.m.
    Type: Grant
    Filed: July 6, 1995
    Date of Patent: April 8, 1997
    Assignees: Sandvik AB, Eurotungstene Poudres S.A.
    Inventors: Stefan Ederyd, Jan kerman, Robert Beaufoy, Michael Carpenter, Maxime Bonneau, Jacques Pillot
  • Patent number: 5441693
    Abstract: The present invention relates to a method of producing a sintered body comprising one or more hard constituents and a binder phase based on cobalt, nickel and/or iron by powder metallurgical methods milling, pressing and sintering of powders. At least part of the binderphase powder consists of non-agglomerated particles of spheroidal morphology having dimensions of 0.1 to 20 .mu.m.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: August 15, 1995
    Assignee: Sandvik AB
    Inventors: Stefan Ederyd, Jan Akerman, Robert Beaufoy, Michael Carpenter, Maxime Bonneau, Jacques Pillot
  • Patent number: 4871659
    Abstract: Anti-NANBH (anti-non-A, non-B hepatitis) antibody comprises IgM isolated from sera of monkeys artificially infected with extracts of feces from patients known to be suffering from epidemic NANB hepatitis. A process for isolating an antibody of this type is provided. A reagent for detecting epidemic NANB hepatitis comprises the anti-NANBH IgM fixed to a solid support. The reagent is useful for diagnosing epidemic NANB viral hepatitis by forming an immunological complex between the anti-NANBH IgM and antigen in a fecal extract from a patient being diagnosed, and then incubating the immunological complex with enzyme-labeled IgG from serum of a human convalescing from epidemic NANBH. The complex is detected by developing the enzyme.
    Type: Grant
    Filed: April 7, 1987
    Date of Patent: October 3, 1989
    Assignee: Institut Pasteur
    Inventor: Jacques Pillot